Prevalence of Human T-Cell Lymphotropic Virus Type 1 and 2 among Blood Donors in Jiangsu from 2016 to 2019.
10.19746/j.cnki.issn.1009-2137.2021.04.046
- Author:
Hui CHEN
1
;
Tao FENG
1
;
Shao-Wen ZHU
1
;
Li-Na CAI
1
;
Bao-An CHEN
2
Author Information
1. Jiangsu Province Blood Center, Nanjing 210042, Jiangsu Province, China.
2. Department of Hematology, Zhongda Hospital Southeast University, Nanjing 210009, Jiangsu Province, China,E-mail: cba8888@hotmail.com.
- Publication Type:Journal Article
- MeSH:
Blood Donors;
Female;
HTLV-II Infections/epidemiology*;
Human T-lymphotropic virus 1;
Humans;
Prevalence;
T-Lymphocytes
- From:
Journal of Experimental Hematology
2021;29(4):1308-1311
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the prevalence of human T-cell lymphotropic virus (HTLV) type-I/II infection among voluntary blood donors in Jiangsu (Nanjing, Suzhou, Xuzhou).
METHODS:From 2016 to 2019, 408 262 samples of voluntary blood donors from four blood stations in Jiangsu Province (Jiangsu Province Blood Center, Nanjing Red Cross Blood Center, Suzhou Central Blood Station, and Xuzhou Central Blood Station) were screened for HTLV-I/II antibody by ELISA. The positive samples were sent to National Center for Clinical Laboratories for confirmation by RT-PCR and Western blot.
RESULTS:The positive rate of HTLV-I/II screened by ELISA was 0.20‰ (82/408 262), and three HTLV-I positive samples were confirmed. The prevalence of HTLV-1 infection was 0.74 per 100 000 (3/408 262). All three donors were female repeated blood donors of childbearing ages.
CONCLUSION:Jiangsu is a low prevalence area of HTLV, and a reasonable blood screening strategy for HTLV can further reduce the risk of transfusion-transmitted virus infection.
